A correction was published for a study on BIM and motoneuron loss in an ALS model
Original source
Correction: The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis. (opens in a new tab)Compass holds only the headline and link for this source, so the summary below is necessarily brief. Please read the original.
Cell Death & Differentiation published an erratum correcting the article titled “The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis.” The available source does not specify what was corrected.
Why this matters
The correction concerns a study of BIM and motoneuron loss in an ALS model. Because no correction details or study results are available here, this report does not establish a treatment change or clinical benefit for people with ALS.
Limitations and context
This is a publication erratum, not a new study report. The source provides only the title and publication metadata, so the nature and significance of the correction cannot be assessed. The underlying study’s design, findings and relevance to patients are not available from the supplied source.